Leptomeningeal tumor in primarchy central nervous system lymphoma: Recognition, significance, and implications

Annals of Neurology - Tập 38 Số 2 - Trang 202-209 - 1995
Casilda Balmaceda1, Jeffrey J. Gaynor, Min Sun, J T Gluck, Lisa M. DeAngelis
1Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA

Tóm tắt

AbstractThe true incidence of leptomeningeal tumor in priMarchy central nervous system lymphoma is unknown. We studied prospectively the cerebrospinal fluid profile of 96 patients without acquired immunodeficiency syndrome but with priMarchy central nervous system lymphoma at diagnosis, at completion of treatment, and at recurrence. Magnetic resonance images and pathology slides were examined for evidence of leptomeningeal tumor. Leptomeningeal tumor was diagnosed by (1) positive findings on cerebrospinal fluid cytology, (2) leptomeningeal or subependymal enhancement on magnetic resonance imaging, or (3) pathological evidence of leptomeningeal tumor. We recorded whether treatment directed against the leptomeninges was given. Cerebrospinal fluid was examined in 86 of 96 patients at diagnosis and 29 of 42 at recurrence. The incidence of leptomeningeal tumor was 42% at diagnosis and 41% at recurrence. Only elevated levels of protein and lactate dehydrogenase isoenzyme‐5 were significantly associated with leptomeningeal tumor (r = 0.012, p = 0.016, respectively). Treatment against the leptomeninges was significantly associated with the probability of achieving a complete response and a longer freedom from relapse. Patients older than 50 years had a worse disease‐specific survival but a similar probability of responding to therapy as younger patients. Our data show that leptomeningeal tumor in priMarchy central nervous system lymphoma is more prevalent than originally thought, and indicate the need for therapy inclusive of the leptomeninges in all patients.

Từ khóa


Tài liệu tham khảo

10.1002/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P

Zimmerman HM, 1975, Malignant lymphomas of the nervous system, Acta Neuropathol (Berl), 69

10.1093/brain/95.2.199

10.1007/BF00328201

10.1148/radiology.167.1.3279454

10.1097/00004728-198805010-00029

10.1227/00006123-198907000-00003

10.1002/1097-0142(19820301)49:5<939::AID-CNCR2820490518>3.0.CO;2-1

10.3171/jns.1986.65.5.0600

10.1212/WNL.40.1.80

Mantel N, 1966, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother Rep, 50, 163

Cox DR, 1972, Regression models and life tables (with discussion), JR Stat Soc Ser B, 34, 187

10.1002/cncr.21979

Loefler JS, 1985, Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival, J Clin Oncol, 3, 490, 10.1200/JCO.1985.3.4.490

Rawlinson DG, 1975, Cytology of the cerebrospinal fluid in primary malignant lymphomas of the nervous system, Acta Neuropathol (Berl), 187

Schmitt‐Graff A, 1983, Cytology of the cerebrospinal fluid in primary malignant lymphomas of the nervous system, Acta Cytol, 27, 267

10.1212/WNL.29.10.1369

10.1056/NEJM198009253031302

10.1111/j.1600-0404.1992.tb04033.x

10.1007/BF02427840

10.1007/BF00308952